Cannapharmarx Stock Market Value

CPMD Stock  USD 0.01  0.0002  2.50%   
CannaPharmaRx's market value is the price at which a share of CannaPharmaRx trades on a public exchange. It measures the collective expectations of CannaPharmaRx investors about its performance. CannaPharmaRx is trading at 0.0078 as of the 2nd of December 2024, a 2.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0038.
With this module, you can estimate the performance of a buy and hold strategy of CannaPharmaRx and determine expected loss or profit from investing in CannaPharmaRx over a given investment horizon. Check out CannaPharmaRx Correlation, CannaPharmaRx Volatility and CannaPharmaRx Alpha and Beta module to complement your research on CannaPharmaRx.
Symbol

Please note, there is a significant difference between CannaPharmaRx's value and its price as these two are different measures arrived at by different means. Investors typically determine if CannaPharmaRx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CannaPharmaRx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CannaPharmaRx 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CannaPharmaRx's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CannaPharmaRx.
0.00
12/13/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
12/02/2024
0.00
If you would invest  0.00  in CannaPharmaRx on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding CannaPharmaRx or generate 0.0% return on investment in CannaPharmaRx over 720 days. CannaPharmaRx is related to or competes with Phibro Animal, Curaleaf Holdings, China Pharma, Universe Pharmaceuticals, Sonoma Pharmaceuticals, and Akanda Corp. CannaPharmaRX, Inc. operates in the cannabis industry in Canada More

CannaPharmaRx Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CannaPharmaRx's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CannaPharmaRx upside and downside potential and time the market with a certain degree of confidence.

CannaPharmaRx Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for CannaPharmaRx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CannaPharmaRx's standard deviation. In reality, there are many statistical measures that can use CannaPharmaRx historical prices to predict the future CannaPharmaRx's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0129.49
Details
Intrinsic
Valuation
LowRealHigh
0.000.0129.49
Details
Naive
Forecast
LowNextHigh
0.00020.0129.49
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details

CannaPharmaRx Backtested Returns

CannaPharmaRx is out of control given 3 months investment horizon. CannaPharmaRx secures Sharpe Ratio (or Efficiency) of 0.0843, which signifies that the company had a 0.0843% return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.48% are justified by taking the suggested risk. Use CannaPharmaRx Risk Adjusted Performance of 0.0712, mean deviation of 14.85, and Downside Deviation of 18.78 to evaluate company specific risk that cannot be diversified away. CannaPharmaRx holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CannaPharmaRx will likely underperform. Use CannaPharmaRx total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on CannaPharmaRx.

Auto-correlation

    
  -0.2  

Insignificant reverse predictability

CannaPharmaRx has insignificant reverse predictability. Overlapping area represents the amount of predictability between CannaPharmaRx time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CannaPharmaRx price movement. The serial correlation of -0.2 indicates that over 20.0% of current CannaPharmaRx price fluctuation can be explain by its past prices.
Correlation Coefficient-0.2
Spearman Rank Test-0.41
Residual Average0.0
Price Variance0.0

CannaPharmaRx lagged returns against current returns

Autocorrelation, which is CannaPharmaRx pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CannaPharmaRx's pink sheet expected returns. We can calculate the autocorrelation of CannaPharmaRx returns to help us make a trade decision. For example, suppose you find that CannaPharmaRx has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

CannaPharmaRx regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CannaPharmaRx pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CannaPharmaRx pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CannaPharmaRx pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

CannaPharmaRx Lagged Returns

When evaluating CannaPharmaRx's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CannaPharmaRx pink sheet have on its future price. CannaPharmaRx autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CannaPharmaRx autocorrelation shows the relationship between CannaPharmaRx pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CannaPharmaRx.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in CannaPharmaRx Pink Sheet

CannaPharmaRx financial ratios help investors to determine whether CannaPharmaRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CannaPharmaRx with respect to the benefits of owning CannaPharmaRx security.